Please login to the form below

Not currently logged in


This page shows the latest Alzheimer news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: success for Pfizer and Lilly arthritis drug, Darzalex soars, IMI launches Accelerator

Daily Brief: success for Pfizer and Lilly arthritis drug, Darzalex soars, IMI launches Accelerator

researchers’time). Many of the proposed projects address brain disorders, such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, major depression, and immune-mediated diseases such as Crohn’s

Latest news

More from news
Approximately 98 fully matching, plus 418 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 2 fully matching, plus 34 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 24 partially matching documents found.

Latest from PMHub

  • Alzheimer’s disease: reviewing the immediate treatment horizon

    Alzheimer’ s disease: reviewing the immediate treatment horizon. Account Manager Stuart Goodman takes a look at some of the promising categories of Phase 3 treatments that could soon be available to ... A recent article by BLH Consultant David Cooney

  • Alzheimer's: the numbers we cannot forget

    I would love to be talking about our latest thinking around launching new therapies in Alzheimer’ s disease (AD) but I can’ t – no one can. ... Among the worst attrition rates in the industry. 99.6% of all trials in Alzheimer’ s disease (AD)

  • Forecasting in Forgotten Markets

    This charitable fund represents collaboration between the Department of Health, Alzheimer’ s Research UK () and a number of Big Pharma companies.

  • Alzheimer's and Brain Awareness Month

    June 2017 is Alzheimer’ s and Brain Awareness Month, which aims to raise awareness about Alzheimer’ s disease (AD) and other types of dementia1. ... 5. Alzheimer's hopes dashed as Lilly gives up on amyloid drug solanezumab.

  • Pragmatic Digital Health

    This can be at an individual level where apps are already at a developmental stage of being able to detect early signs of dementia and Alzheimer’ s through to the huge

More from PMHub
Approximately 4 fully matching, plus 15 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

We're a healthcare communications agency that does things differently. We put patients at the heart of everything we do, while...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....